Walter G. Wasser, MD; Cindy A. Rossi, MA; Gregory E. Glass, PhD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Wasser W., Rossi C., Glass G.; Hantavirus Antibodies in New York. Ann Intern Med. 1997;127:166-167. doi: 10.7326/0003-4819-127-2-199707150-00028
Download citation file:
Published: Ann Intern Med. 1997;127(2):166-167.
TO THE EDITOR:
To clarify an association between end-stage renal disease and antibodies to hantavirus [1, 2], we examined serum samples from patients seen in a dialysis facility and an emergency department in New York City.
Serum samples were screened by enzyme-linked immunosorbent assay (ELISA) using previously described protocols . To confirm the ELISA results, a Western blot analysis of tentatively positive samples was done. Samples with antibodies directed against nucleocapsid protein  were considered seropositive.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only